DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer.

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

NCT01031498 ·Status: COMPLETED ·Phase: PHASE2

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

NCT00104403 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer

NCT02364804 ·Status: COMPLETED

Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting

NCT01993381 ·Status: UNKNOWN

Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)

NCT00211601 ·Status: COMPLETED ·Phase: NA

Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting

NCT02933099 ·Status: UNKNOWN ·Phase: PHASE3

Prevalence of Delayed Chemotherapy Associated Nausea

NCT04342780 ·Status: COMPLETED

Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy

NCT04785495 ·Status: UNKNOWN

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

NCT00954941 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Delayed Nausea and Vomiting

NCT00696280 ·Status: COMPLETED

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade

NCT06080880 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

NCT02445872 ·Status: UNKNOWN ·Phase: PHASE2

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

NCT01640340 ·Status: COMPLETED ·Phase: NA

Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer

NCT00416689 ·Status: COMPLETED

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

NCT00553059 ·Status: COMPLETED ·Phase: PHASE3

Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin

NCT01093690 ·Status: COMPLETED ·Phase: NA

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

NCT00016380 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

NCT01074697 ·Status: COMPLETED ·Phase: PHASE3

ONO-7436 Phase II Study in Japan

NCT00212602 ·Status: COMPLETED ·Phase: PHASE2

A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)

NCT01054456 ·Status: COMPLETED ·Phase: PHASE2

Observational Study on the Use of Akynzeo® in Patients Receiving HEC

NCT03649230 ·Status: COMPLETED

Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.

NCT01913990 ·Status: UNKNOWN ·Phase: PHASE4

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

NCT00343863 ·Status: COMPLETED ·Phase: NA

Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting

NCT02484911 ·Status: COMPLETED ·Phase: PHASE3

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

NCT00952341 ·Status: COMPLETED ·Phase: PHASE3